Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress
2026 Annual Meeting of Stockholders
Leerink Partners Global Healthcare Conference
EADV Late-Breaker Presentation of EVO756 Phase 2 Data in Chronic Inducible Urticaria